🇺🇸 FDA
Patent

US 8822221

Targeted integration into the PPP1R12C locus

granted A61PA61P43/00

Quick answer

US patent 8822221 (Targeted integration into the PPP1R12C locus) held by Sangamo Biosciences, Inc. expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P43/00